Overview

Dexmedetomidine Versus Nalbuphine in Prevention of Emergence Agitation Following Adenotonsillectomy in Pediatrics

Status:
Unknown status
Trial end date:
2019-09-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of the present study is to compare the effect of IV infusion 0.5 µg/kg dexmedetomidine and IV 0.1 mg/kg nalbuphine in preschool children for prevention of emergence agitation after adenotonsillectomy under sevoflurane anesthesia.
Phase:
Phase 1/Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Ain Shams University
Treatments:
Dexmedetomidine
Nalbuphine
Criteria
Inclusion Criteria:

- Children of (American Society of Anesthesiologist)ASA physical status grade I or II.

- Aged 2-5 years

- Undergoing elective adenotonsillectomy.

Exclusion Criteria:

- History of hypersensitivity to the studied drug.

- Refusal of the legal guardian to participate in the study.

- Severely agitated child at induction of anesthesia

- Occurrence of postoperative bleeding at(Post Anesthesia Care Unit) PACU